Analysts Offer Predictions for Medtronic FY2026 Earnings

Medtronic PLC (NYSE:MDT) – Equities research analysts at Leerink Partnrs raised their FY2026 earnings per share estimates for Medtronic in a report issued on Wednesday, August 20th. Leerink Partnrs analyst M. Kratky now expects that the medical technology company will post earnings per share of $5.64 for the year, up from their previous estimate of $5.54. Leerink Partnrs currently has a “Strong-Buy” rating on the stock. The consensus estimate for Medtronic’s current full-year earnings is $5.46 per share. Leerink Partnrs also issued estimates for Medtronic’s FY2028 earnings at $6.54 EPS, FY2029 earnings at $7.02 EPS and FY2030 earnings at $7.53 EPS.

Several other analysts also recently weighed in on MDT. Needham & Company LLC reiterated a “hold” rating on shares of Medtronic in a research report on Thursday, August 14th. Royal Bank Of Canada decreased their price objective on Medtronic from $105.00 to $101.00 and set an “outperform” rating for the company in a report on Thursday, May 22nd. Wolfe Research upgraded Medtronic from an “underperform” rating to a “peer perform” rating in a report on Monday, June 30th. William Blair upgraded Medtronic to a “hold” rating in a report on Friday, July 11th. Finally, Wall Street Zen downgraded Medtronic from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $101.15.

Medtronic Stock Up 1.7%

NYSE:MDT opened at $92.6210 on Friday. Medtronic has a twelve month low of $79.29 and a twelve month high of $96.25. The company has a market cap of $118.72 billion, a price-to-earnings ratio of 25.52, a price-to-earnings-growth ratio of 2.36 and a beta of 0.80. The stock has a fifty day simple moving average of $89.73 and a 200-day simple moving average of $88.01. The company has a current ratio of 1.85, a quick ratio of 1.42 and a debt-to-equity ratio of 0.53.

Medtronic (NYSE:MDT) last released its earnings results on Tuesday, August 19th. The medical technology company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.23 by $0.03. Medtronic had a return on equity of 14.56% and a net margin of 13.63%.The business had revenue of $8.58 billion during the quarter, compared to the consensus estimate of $8.37 billion. During the same period last year, the company earned $1.23 earnings per share. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. Medtronic has set its FY 2026 guidance at 5.600-5.660 EPS.

Institutional Investors Weigh In On Medtronic

A number of large investors have recently modified their holdings of MDT. Norges Bank purchased a new stake in shares of Medtronic during the second quarter worth about $1,432,698,000. Boston Partners grew its stake in shares of Medtronic by 122.8% during the first quarter. Boston Partners now owns 6,912,055 shares of the medical technology company’s stock worth $619,460,000 after acquiring an additional 3,809,450 shares during the last quarter. Ameriprise Financial Inc. grew its stake in shares of Medtronic by 28.8% during the first quarter. Ameriprise Financial Inc. now owns 15,481,028 shares of the medical technology company’s stock worth $1,391,141,000 after acquiring an additional 3,461,221 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Medtronic by 42.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 10,059,135 shares of the medical technology company’s stock worth $903,915,000 after acquiring an additional 3,017,849 shares during the last quarter. Finally, Nuveen LLC purchased a new stake in shares of Medtronic during the first quarter worth about $260,649,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Medtronic Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 17th. Shareholders of record on Friday, September 26th will be paid a $0.71 dividend. This represents a $2.84 annualized dividend and a yield of 3.1%. The ex-dividend date is Friday, September 26th. Medtronic’s payout ratio is 78.24%.

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.